Rare diseases
Investigational molecules
Locations
Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
PortugalStudy on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer
PortugalStudy on Liraglutide for Weight Management in Children Aged 6 to 12 with Obesity
PortugalStudy on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy
PortugalStudy on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors
PortugalStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PortugalStudy on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria
PortugalStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
PortugalStudy on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors
PortugalStudy on the Safety and Effectiveness of Cibotercept (KER-012) with Other Drugs for Adults with Pulmonary Arterial Hypertension
PortugalStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PortugalStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
